Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer

Published:2020-09-01 Issue:9 Volume:6 Page:1410
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Radovich Milan¹,Jiang Guanglong¹,Hancock Bradley A.¹,Chitambar Christopher²,Nanda Rita³,Falkson Carla⁴,Lynce Filipa C.⁵,Gallagher Christopher⁵,Isaacs Claudine⁵,Blaya Marcelo⁶,Paplomata Elisavet⁷,Walling Radhika⁸,Daily Karen⁹,Mahtani Reshma¹⁰,Thompson Michael A.¹¹,Graham Robert¹²,Cooper Maureen E.¹³,Pavlick Dean C.¹³,Albacker Lee A.¹³,Gregg Jeffrey¹³¹⁴,Solzak Jeffrey P.¹,Chen Yu-Hsiang¹,Bales Casey L.¹,Cantor Erica¹,Shen Fei¹,Storniolo Anna Maria V.¹,Badve Sunil¹,Ballinger Tarah J.¹,Chang Chun-Li¹⁵,Zhong Yuan¹⁵,Savran Cagri¹⁵,Miller Kathy D.¹,Schneider Bryan P.¹

Affiliation:

1. Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis

2. Medical College of Wisconsin, Milwaukee

3. University of Chicago, Chicago, Illinois

4. University of Alabama at Birmingham, Birmingham

5. Georgetown University, Washington, DC

6. Memorial Healthcare System, Hollywood, Florida

7. Winship Cancer Institute of Emory University, Atlanta, Georgia

8. Community Regional Cancer Care, Indianapolis, Indiana

9. University of Florida, Gainesville

10. Sylvester Comprehensive Cancer Center, Deerfield Beach, Florida

11. Advocate Aurora Health Care, Milwaukee, Wisconsin

12. Erlanger Health System, Chattanooga, Tennessee

13. Foundation Medicine Inc, Cambridge, Massachusetts

14. University of California at Davis, Davis

15. Purdue University School of Mechanical Engineering, West Lafayette, Indiana

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2768007/jamaoncology_radovich_2020_br_200008_1599147192.25952.pdf

Reference15 articles.

1. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.;Liedtke;J Clin Oncol,2008

2. Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.;Chen;NPJ Breast Cancer,2017

3. Assessment of molecular relapse detection in early-stage breast cancer.;Garcia-Murillas;JAMA Oncol,2019

4. Detection and characterization of carcinoma cells in the blood.;Racila;Proc Natl Acad Sci U S A,1998

5. Circulating tumor cells, disease progression, and survival in metastatic breast cancer.;Cristofanilli;Semin Oncol,2006

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular residual disease (CRD) in early breast cancer –Expanding the concept of minimal residual disease monitoring?;The Journal of Liquid Biopsy;2024-03

2. Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review;Hepatobiliary Surgery and Nutrition;2024-02

3. Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer;Cancer Letters;2024-02

4. Minimal residual disease guided radical chemoradiotherapy combined with immunotherapy after neoadjuvant immunochemotherapy followed by adjuvant immunotherapy for esophageal squamous cell cancer (ECMRD-001): a study protocol for a prospective cohort study;Frontiers in Immunology;2024-01-11

5. The Endpoints Dataset: A Quality Control Method for Review and Analysis of Critical Efficacy Endpoints Data;Journal of the Society for Clinical Data Management;2024-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3